Effect of Androgenisation on the Development of Mammary Tumours in Rats Induced by the Oral Administration of 9,10-Dimethyl-1,2-Benzanthracene
1965
Effect of Androgenisation on Mammary Tumours in Rats
publication
Evidence: moderate
Author Information
Author(s): K. Kovacs
Primary Institution: Department of Pathology, University of Liverpool
Hypothesis
Does androgenisation affect the development of mammary tumours in rats induced by DMBA?
Conclusion
Androgenisation reduces the incidence of mammary tumours in rats treated with DMBA.
Supporting Evidence
- Only one mammary tumour was found in non-androgenised Wistar rats.
- Mammary tumours developed in all non-androgenised Sprague-Dawley rats that survived for 5 months.
- Incidence of mammary tumours was less in androgenised rats compared to non-androgenised rats.
Takeaway
When baby rats get a hormone called testosterone, they have fewer breast tumors later when given a chemical that can cause cancer.
Methodology
Female rats were given testosterone at a young age and then treated with DMBA to observe tumor development.
Limitations
The study had a small number of surviving animals, making it difficult to evaluate results.
Participant Demographics
Female rats of the Wistar and Sprague-Dawley strains.
Want to read the original?
Access the complete publication on the publisher's website